FDA Inspection
Canberra CorporationCanberra Corporation – FDA Inspection, Mar 3, 2010
Record Details
This FDA Inspection record concerns Canberra Corporation, with an inspection on March 3, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Canberra Corporation
- Inspection Date
- March 3, 2010
- Product Type
- Drugs
View Company Profile
ID · bc8dbc82-50d6-4db1-8541-e155e006981a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 648844
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.194(a)(5)Calculations performed are in the records
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Canberra Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 26, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 14, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 11, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Canberra Corporation
- FDA Inspection 871450 - 2014-03-26
- FDA Inspection 816541 - 2013-02-21
- FDA Inspection 683537 - 2010-09-14
- FDA Inspection 674022 - 2010-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.